DAA1211 |
blood HSP70 level increase |
Molecular |
plasma |
Human |
— |
— |
|
DAA696 |
Blood cholesterol increases |
Physiological |
plasma |
Human |
— |
— |
|
DAA675 |
Beta-galactosidase expression increases in mesenchymal stem cells |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA673 |
telomere length in hematopoietic stem cells |
Molecular |
hematopoietic stem cells |
Human |
— |
— |
|
DAA946 |
Thymic hormone levels decrease |
Physiological |
plasma |
Human |
— |
— |
|
DAA612 |
Anemia |
Pathological |
blood |
Human |
— |
SeriesMorbidity |
|
DAA699 |
Triglyceride levels increase |
Physiological |
plasma |
Human |
— |
— |
|
DAA2035 |
Alterations in frequency, developmental potential and gene expression profile in hematopoietic stem cells |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA936 |
Volume of hematopoietic bone marrow decreases |
Physiological |
bone marrow |
Human |
— |
— |
|
DAA912 |
Aldosterone secretion, blood levels and clearance decrease |
Physiological |
plasma, adrenal gland |
Human |
— |
— |
|
DAA909 |
Mean blood glucose level increases |
Physiological |
plasma |
Human |
— |
— |
|
DAA698 |
Albumin levels decrease |
Physiological |
plasma |
Human |
— |
— |
|